Eiger BioPharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eiger BioPharmaceuticals, Inc.
CIK #0001454815, 0001305253
EDGAR Form CIK 2011 - 2024
10-K [0001305253]
10-Q [0001305253]
3 [0001305253]
4 [0001305253]
8-K [0001305253]
D [0001305253]
SC 13D [0001305253]
SC 13G [0001305253]
D [0001454815]
SC 13G [0001454815]
Form 13D/13G Filer Form 13D/13G Subject Filed
Adage Capital Partners GP LLC Eiger Biopharmaceuticals Inc [2022-05-02]
Arkin Moshe Eiger Biopharmaceuticals Inc [2022-03-08]
Ameriprise Financial Inc Eiger Biopharmaceuticals Inc [2022-01-21]
Ameriprise Financial Inc Eiger Biopharmaceuticals Inc [2021-01-11]
BlackRock Inc Eiger Biopharmaceuticals Inc [2020-02-07]
Broadfin Capital LLC Eiger Biopharmaceuticals Inc [2019-06-14]
Cormorant Asset Management LP Eiger Biopharmaceuticals Inc [2019-05-03]
Adage Capital Partners GP LLC Eiger Biopharmaceuticals Inc [2018-10-26]
RA Capital Management LLC Eiger Biopharmaceuticals Inc [2018-10-25]
683 Capital Management LLC Eiger Biopharmaceuticals Inc [2018-10-15]
View All
Form 3/4/5 Subject 2011 - 2024
Vollins James
Eiger BioPharmaceuticals, Inc.
Kachioff William G
Mayer Eldon C. III
Sablich Kim
Loh Evan
Murray Christine
Glenn Jeffrey S
Dietz Thomas John
Kelly-Croswell Lisa
View All
Terms | Privacy | Guide
tony@aum13f.com